|
|||||
|
|
A relative standard for minimal risk is unnecessary and potentially harmful to children: lessons from the Phambili trial |
|
| Authors: | Nelson Robert M |
| Affiliation: | U.S. Food and Drug Administration, Office of Pediatric Therapeutics, Silver Spring 20993-0002, USA. robert.nelson@fda.hhs.gov |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |